Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation
Authors:
- Hiroki MatsumotoHMHiroki Matsumoto
- Hidemi SuzukiHSHidemi Suzuki
- Takahiro YamanakaTYTakahiro Yamanaka
- Taisuke KaihoTKTaisuke Kaiho
- Atsushi HataAHAtsushi Hata
- Terunaga InageTITerunaga Inage
- Takamasa ItoTITakamasa Ito
- Toshiko KamataTKToshiko Kamata
- Kazuhisa TanakaKTKazuhisa Tanaka
- Yuichi SakairiYSYuichi Sakairi
- Shinichiro MotohashiSMShinichiro Motohashi
- Ichiro YoshinoIYIchiro Yoshino
Open Access
Abstract
Antibody-mediated rejection (AMR) is a risk factor for chronic lung allograft dysfunction, which impedes long-term survival after lung transplantation. There are no reports evaluating the efficacy of the single use of anti-CD20 antibodies (aCD20s) in addition to calcineurin inhibitors in preventing AMR. Thus, this study aimed to evaluate the efficacy of aCD20 treatment in a murine orthotopic lung transplantation model. Murine left lung transplantation was performed using a major alloantigen strain mismatch model (BALBc (H-2d) → C57BL/6 (BL/6) (H-2b)). There were four groups: isograft (BL/6→BL/6) (Iso control), no-medication (Allo control), cyclosporine A (CyA) treated, and CyA plus murine aCD20 (CyA+aCD20) treated groups. Severe neutrophil capillaritis, arteritis, and positive lung C4d staining were observed in the allograft model and CyA-only-treated groups. These findings were significantly improved in the CyA+aCD20 group compared with those in the Allo control and CyA groups. The B cell population in the spleen, lymph node, and graft lung as well as the levels of serum donor-specific IgM and interferon γ were significantly lower in the CyA+aCD20 group than in the CyA group. Calcineurin inhibitor-mediated immunosuppression combined with aCD20 therapy effectively suppressed AMR in lung transplantation by reducing donor-specific antibodies and complement activation.Keywords
Funding Information
- Kaken Pharmaceutical (JP20K17739)
This publication has 46 references indexed in Scilit:
- Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLTThe Journal of Heart and Lung Transplantation, 2013
- Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantationThe Journal of Heart and Lung Transplantation, 2013
- Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung TransplantationJournal of Visualized Experiments, 2012
- The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report—2011The Journal of Heart and Lung Transplantation, 2011
- Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantationThe Journal of Heart and Lung Transplantation, 2010
- B Cells Help Alloreactive T Cells Differentiate Into Memory T CellsAmerican Journal of Transplantation, 2010
- Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeysJournal of Clinical Investigation, 2010
- Type V Collagen-Induced Oral Tolerance Plus Low-Dose Cyclosporine Prevents Rejection of MHC Class I and II Incompatible Lung AllograftsThe Journal of Immunology, 2009
- “To B or Not to B?” B-Cells and Graft RejectionTransplantation, 2008
- Cytometric bead array: a multiplexed assay platform with applications in various areas of biologyClinical Immunology, 2004